Answers are grounded in this paper and cite their sources.
This cross-sectional study examines spending on drugs with indications approved by the US Food and Drug Administration and withdrawn from the market from 2015 to 2024.
No takes yet. Share an insight, caveat, or question.
Jazowski et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: